Clinical trials of biologics
The group has a fully staffed clinical trials unit that is world leading in studies of new targeted biological therapies for psoriasis including:
- TNF antagonists
- T cell activation blockers
- IL-12/IL-23 antagonists
The unit was established in 1994 and is one of Europe's leading dermatology clinical trials units.
Study volunteers/patients
We are always looking for normal study volunteers and patients with psoriasis to participate in clinical trials.
For further details, see: Study volunteers